Last reviewed · How we verify

Bupivacaine Hydrochloride And Epinephrine (Bupivacaine Hydrochloride)

Pfizer · FDA-approved approved Small molecule Verified Quality 75/100

Bupivacaine Hydrochloride And Epinephrine (generic name: Bupivacaine Hydrochloride) is a Amide local anesthetic Small molecule drug developed by Pfizer. It is currently FDA-approved (first approved 1972) for Anesthesia for cesarean section, Itching of skin, Local Anesthesia for Ophthalmologic Procedure.

Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.

Bupivacaine hydrochloride is an amide local anesthetic indicated for production of local or regional anesthesia in adults for surgical, dental, diagnostic, therapeutic, and obstetrical procedures. It blocks nerve impulses by increasing electrical excitation threshold with a half-life of 2.7 hours and high protein binding of 95%. Significant risks include contraindication in obstetrical paracervical block and intravenous regional anesthesia, plus severe drug interactions with MAOIs, tricyclic antidepressants, ergot drugs, and nonselective beta-blockers. Clinical use requires careful patient selection and monitoring for systemic toxicity and cardiovascular effects.

At a glance

Generic nameBupivacaine Hydrochloride
SponsorPfizer
Drug classAmide local anesthetic
TargetNerve sodium channels
ModalitySmall molecule
PhaseFDA-approved
First approval1972

Mechanism of action

Bupivacaine blocks the generation and conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. The progression of anesthesia follows a specific order of nerve function loss: pain, temperature, touch, proprioception, and skeletal muscle tone, related to the diameter, myelination, and conduction velocity of affected nerve fibers. Epinephrine is added as a vasoconstrictor to slow absorption into the general circulation and prolong maintenance of active tissue concentration.

Approved indications

Common side effects

Drug interactions

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bupivacaine Hydrochloride And Epinephrine

What is Bupivacaine Hydrochloride And Epinephrine?

Bupivacaine Hydrochloride And Epinephrine (Bupivacaine Hydrochloride) is a Amide local anesthetic drug developed by Pfizer, indicated for Anesthesia for cesarean section, Itching of skin, Local Anesthesia for Ophthalmologic Procedure.

How does Bupivacaine Hydrochloride And Epinephrine work?

Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.

What is Bupivacaine Hydrochloride And Epinephrine used for?

Bupivacaine Hydrochloride And Epinephrine is indicated for Anesthesia for cesarean section, Itching of skin, Local Anesthesia for Ophthalmologic Procedure, Local anesthesia, Local anesthetic intrathecal block.

Who makes Bupivacaine Hydrochloride And Epinephrine?

Bupivacaine Hydrochloride And Epinephrine is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Bupivacaine Hydrochloride And Epinephrine?

Bupivacaine Hydrochloride is the generic (nonproprietary) name of Bupivacaine Hydrochloride And Epinephrine.

What drug class is Bupivacaine Hydrochloride And Epinephrine in?

Bupivacaine Hydrochloride And Epinephrine belongs to the Amide local anesthetic class. See all Amide local anesthetic drugs at /class/amide-local-anesthetic.

When was Bupivacaine Hydrochloride And Epinephrine approved?

Bupivacaine Hydrochloride And Epinephrine was first approved on 1972.

What development phase is Bupivacaine Hydrochloride And Epinephrine in?

Bupivacaine Hydrochloride And Epinephrine is FDA-approved (marketed).

What are the side effects of Bupivacaine Hydrochloride And Epinephrine?

Common side effects of Bupivacaine Hydrochloride And Epinephrine include Headache, Nausea, Constipation, Dizziness, Hypoaesthesia, Paraesthesia.

What does Bupivacaine Hydrochloride And Epinephrine target?

Bupivacaine Hydrochloride And Epinephrine targets Nerve sodium channels and is a Amide local anesthetic.

Related